Literature DB >> 11602625

Antigenicity and immunogenicity of allogeneic retinal transplants.

N G Anosova1, B Illigens, F Boisgérault, E V Fedoseyeva, M J Young, G Benichou.   

Abstract

The transplantation of neuronal cells and tissues represents a promising approach for the treatment of incurable neurodegenerative diseases. Indeed, it has been reported recently that retinal transplantation can rescue photoreceptor cells and delay age-related changes in various retinal layers in rodents. However, retinal grafts deteriorate progressively after placement in recipients' eyes. Here we investigated whether a host's immune response elicited toward the graft contributes to its deterioration. Using an ELISA spot assay, we measured T cell responses to retinal tissues placed in the vitreous cavity of syngeneic and allogeneic mice. We found that allogeneic retinas induced potent alloimmune responses mediated by T cells secreting type 1 cytokines (IFN-gamma and IL-2). No response was found in mice engrafted with syngeneic retinas. In addition, all syngeneic retinal grafts displayed no signs of tissue damage (at 55 days), while the majority of allogeneic retinas deteriorated as early as 12 days after placement. Next, we showed that anti-donor responses occurred within two phenotypically and functionally distinct T cell subsets: CD4+ T cells secreting IL-2 and CD8+ T cells producing IFN-gamma. Importantly, CD4+ T cells were necessary and sufficient to cause graft deterioration, while CD8+ T cells did not contribute to this process.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11602625      PMCID: PMC209524          DOI: 10.1172/JCI12204

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  54 in total

Review 1.  Regional immunity and ocular immune privilege.

Authors:  J W Streilein
Journal:  Chem Immunol       Date:  1999

2.  Role of CD4+ and CD8+ T cells in allorecognition: lessons from corneal transplantation.

Authors:  F Boisgérault; Y Liu; N Anosova; E Ehrlich; M R Dana; G Benichou
Journal:  J Immunol       Date:  2001-08-15       Impact factor: 5.422

3.  CD8+ effector cells responding to residual class I antigens, with help from CD4+ cells stimulated indirectly, cause rejection of "major histocompatibility complex-deficient" skin grafts.

Authors:  R S Lee; M J Grusby; T M Laufer; R Colvin; L H Glimcher; H Auchincloss
Journal:  Transplantation       Date:  1997-04-27       Impact factor: 4.939

4.  Hypothesis: why do so many lymphocytes respond to major histocompatibility antigens?

Authors:  P Matzinger; M J Bevan
Journal:  Cell Immunol       Date:  1977-03-01       Impact factor: 4.868

5.  CD4+ T cells responsive through the indirect pathway can mediate skin graft rejection in the absence of interferon-gamma.

Authors:  A Valujskikh; P S Heeger
Journal:  Transplantation       Date:  2000-03-15       Impact factor: 4.939

6.  Human natural killer cells: a unique innate immunoregulatory role for the CD56(bright) subset.

Authors:  M A Cooper; T A Fehniger; S C Turner; K S Chen; B A Ghaheri; T Ghayur; W E Carson; M A Caligiuri
Journal:  Blood       Date:  2001-05-15       Impact factor: 22.113

Review 7.  Autotoxicity and Alzheimer disease.

Authors:  P L McGeer; E G McGeer
Journal:  Arch Neurol       Date:  2000-06

8.  Transplantation of cultured human retinal epithelium to Bruch's membrane of the owl monkey's eye.

Authors:  P Gouras; M T Flood; H Kjedbye; M K Bilek; H Eggers
Journal:  Curr Eye Res       Date:  1985-03       Impact factor: 2.424

9.  Visualization of myelin basic protein (MBP) T cell epitopes in multiple sclerosis lesions using a monoclonal antibody specific for the human histocompatibility leukocyte antigen (HLA)-DR2-MBP 85-99 complex.

Authors:  M Krogsgaard; K W Wucherpfennig; B Cannella; B E Hansen; A Svejgaard; J Pyrdol; H Ditzel; C Raine; J Engberg; L Fugger; B Canella
Journal:  J Exp Med       Date:  2000-04-17       Impact factor: 14.307

10.  Restoration of immunogenicity to passenger cell-depleted kidney allografts by the addition of donor strain dendritic cells.

Authors:  R I Lechler; J R Batchelor
Journal:  J Exp Med       Date:  1982-01-01       Impact factor: 14.307

View more
  3 in total

1.  A Subsequent Human Neural Progenitor Transplant into the Degenerate Retina Does Not Compromise Initial Graft Survival or Therapeutic Efficacy.

Authors:  Bin Lu; Yanhua Lin; Yuchun Tsai; Sergey Girman; Grazyna Adamus; Melissa K Jones; Brandon Shelley; Clive N Svendsen; Shaomei Wang
Journal:  Transl Vis Sci Technol       Date:  2015-02-10       Impact factor: 3.283

2.  Good news-bad news: the Yin and Yang of immune privilege in the eye.

Authors:  John V Forrester; Heping Xu
Journal:  Front Immunol       Date:  2012-11-27       Impact factor: 7.561

3.  Multimodal Delivery of Isogenic Mesenchymal Stem Cells Yields Synergistic Protection from Retinal Degeneration and Vision Loss.

Authors:  Benjamin Bakondi; Sergey Girman; Bin Lu; Shaomei Wang
Journal:  Stem Cells Transl Med       Date:  2016-09-09       Impact factor: 6.940

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.